| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.006 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |